ACP-105 – High-Performance SARM for Lean Muscle, Strength & Cognitive Optimization.
 
ACP-105 is a next-generation Selective Androgen Receptor Modulator (SARM) designed to deliver the anabolic benefits of traditional anabolic steroids—such as muscle growth and increased strength—while minimizing systemic side effects. Originally developed by ACADIA Pharmaceuticals, ACP-105 has attracted attention in both the fitness and research communities due to its potent, selective action on androgen receptors in muscle and bone tissue.
 
 
🔬 Selective Anabolic Action with a Superior Safety Profile
Unlike conventional anabolic steroids, ACP-105 acts with high selectivity, binding specifically to androgen receptors in skeletal muscle and bone, without activating receptors in unwanted tissues like the prostate or liver. This targeted mechanism ensures efficient anabolic effects while minimizing the risk of unwanted hormonal or organ-related side effects.
 
 
✅ Key Benefits of ACP-105
1. Rapid Lean Muscle Growth
ACP-105 significantly enhances protein synthesis and muscle regeneration, contributing to noticeable gains in lean muscle mass without water retention. It is ideal for individuals aiming for clean bulking or body recomposition phases.
2. Enhanced Strength and Power Output
The selective stimulation of muscle androgen receptors supports dramatic improvements in strength, endurance, and overall training capacity. Users commonly report increased lifting capacity and shorter recovery between training sessions.
3. Neuroprotective and Cognitive Benefits
Emerging research suggests that ACP-105 may have positive effects on brain health and cognitive function, making it a unique compound among SARMs. Studies have indicated potential neuroprotective properties, particularly in degenerative models.
4. Bone Density and Joint Protection
ACP-105 promotes increased bone mineral density, supporting structural integrity and reducing the risk of injuries. This benefit is especially valuable for aging populations or athletes engaged in high-impact sports.
5. Minimal Side Effects and Hormonal Disruption
As a non-steroidal compound, ACP-105 does not aromatize into estrogen, does not exhibit significant liver toxicity, and shows minimal suppression of endogenous testosterone production in short-term use. This reduces or eliminates the need for aggressive post-cycle therapy (PCT).
6. Excellent Bioavailability and Simple Dosing
ACP-105 has good oral bioavailability with a half-life of approximately 4–6 hours, allowing for once-daily administration while maintaining stable and effective blood levels. Experimental dosages typically range between 5 to 10 mg per day in research settings.
 
 
📈 Why Choose ACP-105?
Targeted anabolic action on muscle and bone
No conversion to estrogen (no water retention or gynecomastia)
Rapid improvements in performance and recovery
Promising effects on cognition and brain function
No significant impact on liver enzymes or prostate tissue
Suitable for both research and performance-focused applications
 
 
⚠️ Disclaimer
ACP-105 is an investigational compound intended for research and educational purposes only. It has not been approved for human consumption or therapeutic use. The information provided here is based on preclinical data, anecdotal reports, and technical analyses, and should not be interpreted as medical advice.